UpdatesPress Release
Balaji Amines reported Q4FY26 consolidated revenue of ₹403 Cr, EBITDA ₹102 Cr, and PAT ₹65 Cr.
Balaji Amines LimitedBALAMINES · Filed with the exchange
New projects including DME, NMM, Acetonitrile, and a ₹750 Cr subsidiary expansion are underway, funded internally.
The company remains standalone debt-free, showing resilience amidst operational disruptions.
No comments yet. Be the first.